Clin2
NCT07847892Possibly a fitNot yet recruiting

Long-term follow-up study for gamgertamig responders

Autoimmune Cytopenias

Part of Blood & lymphatic clinical trials.

This study follows people who have already finished treatment with the study drug gamgertamig and are doing well. It checks on their health over time to see how long the benefits last.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
100 people
Ages
18 years to 75 years
Study type
Observational

Who can take part

  • You finished the full treatment plan in a previous gamgertamig study.
  • You had a good response to the treatment and it is still working.
  • You are able to give your informed consent to join.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06652633Recruiting· Phase 3
Long-term follow-up of Galapagos CAR T-cell therapy recipients

This study is for people who have already received a specific type of cell therapy (CAR T-cell therapy) made by Galapagos. It will follow them over the long term to see how they are doing.

Boston, Massachusetts
NCT05049668Enrolling by invitation
Long-term follow-up for people from the RACE study

This study checks on people who took part in the earlier RACE trial and collected long-term health information. It helps researchers understand how the treatments given in that trial affect patients over time.

Paris
NCT06925685Enrolling by invitation
Long-term follow-up after CAR T-cell therapy

This study monitors participants who received a certain type of CAR T-cell therapy for cancer. It helps researchers understand long-term effects and safety.

Buffalo, New York
NCT03628612Enrolling by invitation· Phase 2
Long-term follow-up after CAR T cell treatment

This study checks how people do over the long run after receiving a personalized, genetically modified CAR T cell treatment. It may help researchers understand long-term safety and outcomes, which can improve future care.

Miami, Florida
NCT06208878Enrolling by invitation
Long-term follow-up for CRISPR CAR T therapy recipients

This study follows people who have already received a CRISPR CAR T cell therapy to monitor their long-term health and any side effects. It helps doctors understand how these treatments work over time.

Duarte, California
NCT05529342Enrolling by invitation
Long-term follow-up for a prior gene-cell treatment

This study follows people long-term after receiving a specific gene-cell treatment called AGT103-T. It helps researchers check long-term safety and outcomes, which can guide future care for others.

Washington D.C., District of Columbia

Hear when a new Autoimmune Cytopenias trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.